CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease.
Smith
Patrice D
PD
Ottawa Health Research Institute, Neuroscience Group, Ottawa, Ontario, Canada K1H8M5.
O'Hare
Michael J
MJ
Park
David S
DS
D000818:Animals; D016923:Cell Death / Q000502:physiology*; D018844:Cyclin-Dependent Kinases / Q000235:genetics / Q000378:metabolism* / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008938:Mitosis / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000201:enzymology*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*
D018844:Cyclin-Dependent Kinases; D004298:Dopamine